Clinical Trial Detail

NCT ID NCT02723435
Title Midostaurin in Treating Older Patients With Mutated Acute Myeloid Leukemia Post-Transplant
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Stanford University
Indications

acute myeloid leukemia

Therapies

Midostaurin

Age Groups: senior

Additional content available in CKB BOOST